CARsgen Therapeutics Holdings Limited

18 JUN 2021

CARsgen Therapeutics Holdings Limited is a biopharmaceutical company with operations in China and the U.S. focused on innovative CAR-T cell therapies for the treatment of hematological malignancies and solid tumors. The company has developed technologies and a product pipeline with global rights to address challenges of CAR-T cell therapies, such as improving the safety profile, enhancing the efficacy in treating solid tumors, and reducing treatment costs.